Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index.

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

Abstract

BACKGROUND: Although several agents are available to treat osteoporosis, the relative efficacy and toxicity of these agents when used to prevent fractures has not been well described. PURPOSE: To compare the benefits in fracture reduction and the harms from adverse events of various therapies for osteoporosis. DATA SOURCES: MEDLINE (1966 to November 2007) and other selected databases were searched for English-language studies. STUDY SELECTION: For the efficacy analysis, investigators selected studies that reported the rate of or risk for fractures. For the adverse event analysis, they selected studies that reported the relationship between an agent and cardiovascular, thromboembolic, or upper gastrointestinal events; malignant conditions; and osteonecrosis. DATA EXTRACTION: Using a standardized protocol, investigators abstracted data on fractures and adverse events, agents and comparators, study design, and variables of methodological quality. DATA SYNTHESIS: Good evidence suggests that alendronate, etidronate, ibandronate, risedronate, zoledronic acid, estrogen, parathyroid hormone (1-34), and raloxifene prevent vertebral fractures more than placebo; the evidence for calcitonin was fair. Good evidence suggests that alendronate, risedronate, and estrogen prevent hip fractures more than placebo; the evidence for zoledronic acid was fair. The effects of vitamin D varied with dose, analogue, and study population for both vertebral and hip fractures. Raloxifene, estrogen, and estrogen-progestin increased the risk for thromboembolic events, and etidronate increased the risk for esophageal ulcerations and gastrointestinal perforations, ulcerations, and bleeding. LIMITATION: Few studies have directly compared different agents or classes of agents used to treat osteoporosis. CONCLUSION: Although good evidence suggests that many agents are effective in preventing osteoporotic fractures, the data are insufficient to determine the relative efficacy or safety of these agents.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-148-3-200802050-00198

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

10 retracted

Show all 161 references

Research works printed but not linked: 20

  1. Cranney A, 2001, Cochrane Database Syst Rev, CD003376
  2. Cranney A, 2000, Cochrane Database Syst Rev, CD001983
  3. Avenell A, 2005, Cochrane Database Syst Rev, CD000227
  4. Palmer S, 2005, Cochrane Database Syst Rev, CD005015
  5. Bone HG, 2000, J Clin Endocrinol Metab, 85, 720
  6. Sato S, 2003, J Rheumatol, 30, 2673
  7. Homik J, 2000, Cochrane Database Syst Rev, CD001347
  8. Reid IR, 1994, J Clin Endocrinol Metab, 79, 1595
  9. Homik JE, 1999, J Rheumatol, 26, 1148
  10. Muscoso E, 2004, Eur Rev Med Pharmacol Sci, 8, 97
  11. 10.1359/jbmr.2003.18.1.9 · DOI · Paper page
  12. Blair MM, 2000, J Fam Pract, 49, 839
  13. 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W · doi:10.1002/1529-0131(200101)44:1<202::aid-anr27>3.0.co;2-w
  14. 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K · DOI · Paper page
  15. Cortet B, 1999, Rev Rhum Engl Ed, 66, 214
  16. Zheng S, 2003, Chin Med J (Engl), 116, 1127
  17. 10.1210/jcem.87.3.8325 · doi:10.1210/jcem.87.3.8325 · Paper page
  18. Meunier PJ, 1997, J Clin Endocrinol Metab, 82, 2784
  19. Silberstein EB, 1992, J Nucl Med, 33, 1
  20. Geusens P, 1997, Bone, 20, 9S

Cited by

See all 531

Metadata

Authors
MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., Desai, S. B., Zhou, A., Chen, S., Carter, J., Tringale, C., Valentine, D., Johnsen, B., & Grossman, J.
Affiliations
RAND Corporation (US)
Venue
Annals of Internal Medicine
Published
2008-02-05
Volume
148
Issue
3
Pages
197-213
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2106649747
Cited by
529
References
161
Citations by year
2026: 8 · 2025: 5 · 2024: 10 · 2023: 11 · 2022: 4 · 2021: 12 · 2020: 24 · 2019: 20 · 2018: 15 · 2017: 23 · 2016: 22 · 2015: 32 · 2014: 34 · 2013: 44 · 2012: 42
FWCI
11.64
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Public Health Service (290-02-003)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
osteoporosis, osteoporotic fracture prevention, osteopenia, comparative effectiveness, bisphosphonates, alendronate, risedronate, zoledronic acid, etidronate, ibandronate, estrogen, raloxifene, parathyroid hormone, calcitonin, vitamin D, thromboembolic events, gastrointestinal adverse effects, vertebral fractures, hip fracture, sex differences
MeSH terms
Androgens, Calcium, Estrogens, Female, Humans, Male, Osteoporosis, Risk Factors, Testosterone, Vitamin D, Bone Density, Estrogen Replacement Therapy, Selective Estrogen Receptor Modulators, Bone Density Conservation Agents, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis. https://app.cochat.ai/papers/10.7326/0003-4819-148-3-200802050-00198
The paper
MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., Desai, S. B., Zhou, A., Chen, S., Carter, J., Tringale, C., Valentine, D., Johnsen, B., & Grossman, J. (2008). Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-148-3-200802050-00198

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.